Folgen
Thomas Eigentler
Thomas Eigentler
Department of Dermatology, Venereology and Allergology, Charité Berlin
Bestätigte E-Mail-Adresse bei charite.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
A Ribas, I Puzanov, R Dummer, D Schadendorf, O Hamid, C Robert, ...
The lancet oncology 16 (8), 908-918, 2015
17682015
Epidemiology of skin cancer
J Reichrath, U Leiter, T Eigentler, C Garbe
Sunlight, vitamin D and skin cancer, 120-140, 2014
8132014
Systematic review of medical treatment in melanoma: current status and future prospects
C Garbe, TK Eigentler, U Keilholz, A Hauschild, JM Kirkwood
The oncologist 16 (1), 5-24, 2011
7402011
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
L Hofmann, A Forschner, C Loquai, SM Goldinger, L Zimmer, S Ugurel, ...
European journal of cancer 60, 190-209, 2016
6822016
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the …
R Gutzmer, D Stroyakovskiy, H Gogas, C Robert, K Lewis, S Protsenko, ...
The Lancet 395 (10240), 1835-1844, 2020
5962020
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
L Zimmer, SM Goldinger, L Hofmann, C Loquai, S Ugurel, I Thomas, ...
European journal of cancer 60, 210-225, 2016
5822016
Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab
A Martens, K Wistuba-Hamprecht, MG Foppen, J Yuan, MA Postow, ...
Clinical Cancer Research 22 (12), 2908-2918, 2016
5632016
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
CJ Voskens, SM Goldinger, C Loquai, C Robert, KC Kaehler, C Berking, ...
PloS one 8 (1), e53745, 2013
4952013
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients
B Weide, S Pascolo, B Scheel, E Derhovanessian, A Pflugfelder, ...
Journal of immunotherapy 32 (5), 498-507, 2009
4692009
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
TK Eigentler, JC Hassel, C Berking, J Aberle, O Bachmann, V Grünwald, ...
Cancer treatment reviews 45, 7-18, 2016
4462016
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
TK Eigentler, UM Caroli, P Radny, C Garbe
The lancet oncology 4 (12), 748-759, 2003
4222003
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
B Weide, JP Carralot, A Reese, B Scheel, TK Eigentler, I Hoerr, ...
Journal of immunotherapy 31 (2), 180-188, 2008
3582008
Evaluation of two dosing regimens for nivolumab in combination with ipilimumab in patients with advanced melanoma: results from the phase IIIb/IV CheckMate 511 trial
C Lebbé, N Meyer, L Mortier, I Marquez-Rodas, C Robert, P Rutkowski, ...
Journal of Clinical Oncology 37 (11), 867-875, 2019
3272019
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions
JC Hassel, L Heinzerling, J Aberle, O Bähr, TK Eigentler, MO Grimm, ...
Cancer treatment reviews 57, 36-49, 2017
3212017
Malignant melanoma S3‐guideline “diagnosis, therapy and follow‐up of melanoma”
A Pflugfelder, C Kochs, A Blum, M Capellaro, C Czeschik, T Dettenborn, ...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (s6), 1-116, 2013
3092013
Age and gender are significant independent predictors of survival in primary cutaneous melanoma
K Lasithiotakis, U Leiter, F Meier, T Eigentler, G Metzler, M Moehrle, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
3002008
Diagnosis and treatment of cutaneous melanoma: state of the art 2006
C Garbe, TK Eigentler
Melanoma research 17 (2), 117-127, 2007
2862007
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised …
L Zimmer, E Livingstone, JC Hassel, M Fluck, T Eigentler, C Loquai, ...
The Lancet 395 (10236), 1558-1568, 2020
2452020
Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant …
C Pfannenberg, P Aschoff, S Schanz, SM Eschmann, C Plathow, ...
European Journal of Cancer 43 (3), 557-564, 2007
2232007
Incidence, mortality, and trends of nonmelanoma skin cancer in Germany
U Leiter, U Keim, T Eigentler, A Katalinic, B Holleczek, P Martus, C Garbe
Journal of Investigative Dermatology 137 (9), 1860-1867, 2017
2202017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20